Enterprise Value
$173.93 M
+$18.14 M+11.65%
Wed, 27 Nov 2024 22:27:57 GMT
Summary:
Inhibikase Therapeutics enterprise value is currently $173.93 million, with a rise of +$18.14 million (+11.65%) during the most recent trading day. Over the past year, it has increased by +$183.15 million (+1986.54%). IKT enterprise value is now -13.38% below its all-time high of $200.81 million.IKT Enterprise Value Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
IKT Enterprise Value Performance
| PeriodPeriod | Enterprise valueEnterprise value | Market capMarket cap | PricePrice |
|---|---|---|---|
| todaytoday | +11.7% | +11.6% | +11.6% |
| 1 m1 month | +9.6% | +9.6% | +7.3% |
| 3 m3 months | +2206.5% | +1571.8% | +85.7% |
| 6 m6 months | +1247.0% | +1060.3% | +36.8% |
| ytdytd | +10000.0% | +2177.4% | +109.7% |
| 1 y1 year | +1986.5% | +3152.3% | +198.8% |
| 5 y5 years | - | - | - |
IKT Enterprise Value High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | $201 M | -13.4% | $132 M | +32.2% |
| 3 m | 3 months | $201 M | -13.4% | $5.68 M | +2964.9% |
| 6 m | 6 months | $201 M | -13.4% | $5.40 M | +3122.8% |
| 1 y | 1 year | $201 M | -13.4% | -$9 M | +1986.5% |
| 3 y | 3 years | $201 M | -13.4% | -$21 M | +939.5% |
| 5 y | 5 years | $201 M | -13.4% | -$21 M | +939.5% |
| alltime | all time | $201 M | -13.4% | -$21 M | +939.5% |
Inhibikase Therapeutics Enterprise Value History
| Date | Value |
|---|---|
| 2024 | $173.93 M(<-9900.0%) |
| 2023 | -$1.25 M(-121.7%) |
| Date | Value |
|---|---|
| 2022 | $5.78 M(-263.9%) |
| 2021 | -$3.52 M(-106.3%) |
| 2020 | $55.71 M |
FAQ
- What is Inhibikase Therapeutics enterprise value?
- What is the all time high enterprise value for Inhibikase Therapeutics?
- What is IKT enterprise value year-to-date change?
- What is Inhibikase Therapeutics enterprise value year-on-year change?
What is Inhibikase Therapeutics enterprise value?
The current enterprise value of IKT is $173.93 M
What is the all time high enterprise value for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high enterprise value is $200.81 M
What is IKT enterprise value year-to-date change?
Inhibikase Therapeutics enterprise value has changed by +$175.19 M (+13970.35%) since the beginning of the year
What is Inhibikase Therapeutics enterprise value year-on-year change?
Over the past year, IKT enterprise value has changed by +$183.15 M (+1986.54%)